Description
ECO-RESET: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Location: PAMF (Peninsula/South Bay)
Please contact: Elizabeth Jameiro jameire@sutterhealth.org about study SERES 201
View study details on ClinicalTrials.gov
Principal Investigator
Co-Investigator(s)
Recruitment Status
Active, Recruiting
Start Date
May 10, 2019
Related Studies
Transforming Primary and Specialty Care for Inflammatory Bowel Disease
Investigator(s): Alice R. Pressman, Ph.D., M.S.